Business Categories
PCD Pharma

Medizia Biotech Dealership & Distributorship Cost – How to get, Contact, Apply, Fee

  • Area Req
    100 - 200 Sq.ft
  • Investment Range
    INR 10000 - 50 K
  • No. Of Dealer/Distributor
    200-500

About brand - Medizia Biotech

Medizia Biotech: Pioneering Excellence in Pharmaceutical Injectable Formulations

In the dynamic and ever-evolving landscape of the pharmaceutical industry, innovation, quality, and reliability stand as pillars that determine the success and trustworthiness of any company. Medizia Biotech embodies these pillars, standing tall as a global pharmaceutical manufacturing company specializing in the development of innovative injectable formulations. With robust certifications and adherence to stringent quality norms, Medizia Biotech has carved a niche for itself as a reliable partner for third-party manufacturing and PCD pharma franchise opportunities, particularly in the critical care segment, catering to both domestic and international markets.

Commitment to Innovation and Quality

Medizia Biotech’s foundation is deeply rooted in the pursuit of excellence and innovation in pharmaceutical manufacturing. The company operates under the highest standards of quality and safety, being WHO-GMP, ISO 9001:2015, and DCGI certified. These certifications not only affirm compliance with global manufacturing practices but also reflect the company’s unwavering commitment to producing safe and effective injectable medicines that can improve patient outcomes.

Innovation at Medizia Biotech is not just about developing new formulations; it is about improving existing ones to increase efficacy, reduce side effects, and enhance patient compliance. The company invests significantly in research and development, employing cutting-edge technologies and best-grade chemical compounds to ensure that every product meets the highest standards of medical industry norms.

Product Range: Catering to Critical Care Needs

Medizia Biotech specializes in a diverse range of injectable pharmaceuticals, focusing particularly on critical care therapeutic areas. The company’s portfolio includes critical care antibiotic injections, gastroenterology injections, cardiology injections, antimalarial injections, analgesics, and NSAIDs. These product categories highlight the company’s dedication to addressing some of the most urgent and life-threatening health conditions.

  • Critical Care Antibiotic Injections: These are vital in combating severe infections and sepsis, often administered in intensive care units. Medizia Biotech ensures these antibiotics are formulated to provide rapid and effective therapeutic action.
  • Gastroenterology Injections: Designed to manage acute gastrointestinal disorders, these injections aid in the treatment of critical digestive issues that require prompt intervention.
  • Cardiology Injections: Targeting heart-related conditions, these injectable formulations are crafted to provide quick relief and support in cardiovascular emergencies.
  • Antimalarial Injections: Malaria remains a significant health challenge in many parts of the world. Medizia Biotech produces effective antimalarial injectables that play a crucial role in managing this disease, particularly in severe cases.
  • Analgesics and NSAIDs: Pain management is a critical aspect of healthcare, especially in acute and chronic conditions. Medizia Biotech’s range of analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) ensures potent and reliable pain relief.

Advanced Manufacturing and Quality Control Facilities

One of the standout features of Medizia Biotech is its state-of-the-art manufacturing unit equipped with advanced machinery and technology. This allows the company to produce a wide range of injectable forms, ensuring versatility and comprehensive coverage of pharmaceutical needs.

  • WHO-GMP Certified Facilities: The manufacturing plants operate under strict WHO-GMP guidelines, ensuring that each batch of products undergoes rigorous scrutiny and quality checks.
  • Analytical Research Laboratory: Medizia Biotech boasts a dedicated quality control and analytical research laboratory. Here, each product batch is meticulously tested against multiple parameters to verify its safety, potency, and purity before it reaches the market.
  • Modern Processing Techniques: The company leverages the latest pharmaceutical manufacturing technologies that enable precision formulation, aseptic processing, and contamination control. These ensure that injectable medicines are not only effective but also safe for patient use.
  • Stringent Quality Parameters: All raw materials are sourced from reputed and ethically compliant suppliers. Each ingredient is tested and validated before use, reinforcing the company’s promise of consistent product quality.

Third Party Manufacturing and Franchise Opportunities

Understanding the growing demands of the pharmaceutical sector, Medizia Biotech offers comprehensive third-party manufacturing services. This facility allows other pharmaceutical companies and entrepreneurs to partner with Medizia for producing high-quality injectable formulations under their brand names.

  • Flexible Production Capacity: The company caters to both small and large-scale manufacturing orders, ensuring timely delivery regardless of order size.
  • Seamless Collaboration: Medizia Biotech provides full support to its partners, including regulatory assistance, product development, and marketing strategies, making it a preferred collaborator in the pharmaceutical manufacturing landscape.

Additionally, Medizia Biotech offers PCD (Propaganda-Cum-Distribution) pharma franchise opportunities, providing entrepreneurs with a chance to enter the lucrative critical care pharmaceutical market with established products backed by high manufacturing standards.

Commitment to Consumer Satisfaction

At the heart of Medizia Biotech’s operational philosophy is the commitment to consumer satisfaction. The company recognizes that healthcare products are not merely commodities but essential components that influence lives profoundly.

  • Patient-Centric Approach: Every stage of product development and manufacturing is geared towards delivering safe, effective, and affordable medicines that patients can trust.
  • Quality Assurance: Medizia Biotech’s relentless focus on quality assurance ensures that each injectable formulation meets or exceeds the expectations of healthcare providers and patients alike.
  • Reliability: By maintaining consistency in product quality and supply, Medizia Biotech has gained the confidence of healthcare professionals and institutions, establishing itself as a trusted name in critical care pharmaceuticals.

Vision and Values: Driving Excellence and Impact

Medizia Biotech’s vision goes beyond business success; it is committed to advancing healthcare by discovering and delivering innovative pharmaceutical solutions that save and improve lives. This vision is underpinned by a set of core values that define the company’s culture and approach:

  • Integrity: Conducting business with honesty, transparency, and adherence to ethical standards.
  • Innovation: Continuously improving and developing new pharmaceutical formulations that respond to unmet medical needs.
  • Quality: Upholding the highest standards of manufacturing and quality control.
  • Customer Focus: Prioritizing the needs and satisfaction of clients and patients.
  • Social Responsibility: Contributing positively to society by making life-saving medicines accessible and affordable.

These values create a framework within which Medizia Biotech operates, ensuring that every product, service, and partnership aligns with the overarching goal of enhancing health outcomes globally.

Global Reach and Impact

Though rooted in its origins, Medizia Biotech has expanded its presence to serve markets worldwide. Its adherence to international quality standards enables the company to export pharmaceutical injectables across various countries, catering to diverse healthcare systems and patient populations.

  • International Quality Compliance: The company’s manufacturing practices and product testing are designed to meet international regulatory requirements, facilitating seamless entry into foreign markets.
  • Collaborative Growth: By partnering with distributors and franchisees globally, Medizia Biotech amplifies its impact and reaches patients who require critical care medications.
  • Research and Development Collaboration: Medizia Biotech collaborates with research institutions and medical professionals to continuously enhance its product portfolio and address emerging healthcare challenges.

Focus on Intensive Care Therapeutics

The company’s specialization in critical care pharmaceuticals highlights its role in supporting one of the most demanding segments of healthcare. Intensive care units require medications that are effective, fast-acting, and reliable to manage life-threatening conditions.

  • Precision Formulations: Injectable medicines used in critical care must meet exacting standards for sterility, potency, and safety. Medizia Biotech’s expertise ensures these formulations deliver optimal therapeutic effects.
  • Wide Therapeutic Coverage: From antibiotics that fight severe infections to cardiology injectables that stabilize heart conditions, the company covers a broad spectrum of critical care needs.
  • Timely Delivery: Recognizing the urgency in critical care, Medizia Biotech’s efficient manufacturing and supply chain operations guarantee timely availability of medicines.

Medizia Biotech – A Beacon of Pharmaceutical Excellence

In a world where healthcare demands are growing rapidly and complexity is increasing, Medizia Biotech stands as a beacon of innovation, quality, and reliability. With a focus on injectable pharmaceutical formulations for critical care, the company fulfills a crucial role in improving patient outcomes across multiple therapeutic areas.

Its robust manufacturing infrastructure, commitment to stringent quality control, and dedication to customer satisfaction have made Medizia Biotech a trusted partner for third-party manufacturing and franchise opportunities. The company’s vision to discover and provide innovative pharmaceutical products resonates in every aspect of its operations, promising a healthier future for patients and healthcare providers worldwide.

Medizia Biotech continues to set new benchmarks in pharmaceutical manufacturing, driven by a passion to improve lives through science and compassion. Its journey is a testament to the power of dedication, expertise, and the relentless pursuit of excellence in healthcare.

Medizia Biotech Franchise Cost & Investment

Commenced Operations

Operations Commenced On 2018

Distribution Commenced On 2018

Distribution Details
Trade partners
Types of Channels Investment (If any) Margin / Commissions Area Requirement
Distributor Rs. 10000 - 50000 0% NIL
Details

Performance guarantee to Channel Partner Yes

Anticipated percentage return on investment 40 %

Likely pay back period of capital for a Channel Partner 1-2 Years

Medizia Biotech Expansion Plans

North

Delhi, Haryana, Himachal Pradesh, Jammu and Kashmir, Punjab, Uttarakhand, Uttar Pradesh

South

Kerala, Karnataka, Tamil Nadu, Andhra Pradesh, Telangana

East

Assam, Meghalaya, Mizoram, Tripura, Arunachal Pradesh, Manipur, Nagaland, West Bengal, Sikkim, Odisha

West

Gujarat, Rajasthan, Maharashtra, Goa

Central

Chhattisgarh, Madhya Pradesh, Bihar, Jharkhand

Union Territories

Andaman and Nicobar, Pondicherry, Chandigarh, Lakshadweep, Daman and Diu, Ladakh

 

Tags: Dealers & Distributors Business Franchise in Delhi   |   Dealers & Distributors Business Franchise in Haryana   |   Dealers & Distributors Business Franchise in Himachal Pradesh   |   Dealers & Distributors Business Franchise in Jammu and Kashmir   |   Dealers & Distributors Business Franchise in Punjab   |   Show more...

Medizia Biotech Franchise Requirements

Type of property required for this dealership opportunity Commercial

Floor area requirement 100 - 200 Sq.ft

Preferred location of unit dealership outlet PAN india

Medizia Biotech Franchise Agreement Details

Do you have a standard dealership agreement? Yes

How long is the dealership term for? 5 Years

Is the term renewable? Yes

Disclaimer: Franchise India is an integrated franchise solution company since 1999, and an absolute authority on franchising and licensing. FIHL (www.franchiseindia.com) and the site sponsors accept no liability for the accuracy of any information contained on this site or on other linked sites. We recommend you take advice from a lawyer, accountant and franchise consultant experienced in franchising before you commit yourself. It is user’s responsibility to satisfy yourself as to the accuracy and reliability of the information supplied. Please read the terms & conditions on Franchise India.

How to get Medizia Biotech Franchise

Franchise India stands as a premier platform offering a wide spectrum of franchise opportunities across diverse industries. Embarking on your entrepreneurial journey through a franchise presents a promising venture. To get information about Medizia Biotech franchise, you can fill up the application form provided on the website and get all the details viz. Medizia Biotech franchise fee, Medizia Biotech franchise cost, Medizia Biotech apply process and more.

Interested in Medizia Biotech Franchise? Apply here

Insta Apply
YOU MIGHT ALSO BE INTERESTED IN THESE FRANCHISE OPPORTUNITIES
  • Farming Tools, equipments & Machines
    AVPL International – Pioneering Drone Technology & Training Our Offerings: 1. AVPL..
    Locations looking for expansion Haryana
    Establishment year 2016
    Franchising Launch Date 2025
    Investment size Rs. 5lakh - 10lakh
    Space required 200
    Franchise Outlets -NA-
    Franchise Type Unit, Multiunit
    Headquarter Gurgaon Haryana
  • Two Wheeler & Parts
    Buy → Refurbish → Sell → After Sales Experience the Future..
    Locations looking for expansion Tamil nadu
    Establishment year 2020
    Franchising Launch Date 2021
    Investment size
    Space required 800
    Franchise Outlets -NA-
    Franchise Type -NA-
    Headquarter Coimbatore Tamil nadu
  • Builder & Construction Hardware
    About us Overview: Wehouse (formerly Hocomoco) - TIMESHELL CIVIC PROJECTS..
    Locations looking for expansion Andhra pradesh
    Establishment year 2020
    Franchising Launch Date 2025
    Investment size Rs. 30lakh - 50lakh
    Space required 500
    Franchise Outlets -NA-
    Franchise Type Unit, Multiunit
    Headquarter Khairatabad Andhra pradesh
  • Beverages
    History of PappuDaddu Healthy Foods: PappuDaddu Healthy Foods was founded with..
    Locations looking for expansion Tamil nadu
    Establishment year 2024
    Franchising Launch Date 2024
    Investment size
    Space required 100
    Franchise Outlets -NA-
    Franchise Type -NA-
    Headquarter Tambaram Tamil nadu
  • Solar Products
    In a move to boost the adoption of solar energy..
    Locations looking for expansion Maharashtra
    Establishment year 2011
    Franchising Launch Date 2011
    Investment size Rs. 50000 - 2lakh
    Space required 100
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquarter Malad west Maharashtra
  • Healthcare & Medical Products
    Arogyamithra (Safedrugs Health Solutions) is a pioneering healthcare startup dedicated to..
    Locations looking for expansion Telangana
    Establishment year 2021
    Franchising Launch Date 2022
    Investment size
    Space required 100
    Franchise Outlets -NA-
    Franchise Type -NA-
    Headquarter Hyderabad Telangana
Apply Now

Free Advice - Ask Our Experts

pincode
;
ads ads ads ads